---
type: industry_information
cover:
- "../images/untitled-design-30.png"
date: 2021-12-07T00:00:00.000+08:00
title: Starting from November 2020, the Take2 Prophecy™ Test for Nasopharyngeal Cancer
  and other health assessment services officially joined the CXA’s wellness provider
  network, providing the innovative medical solution to Hong Kong users.
detail: The Take2 Prophecy™ Test for Nasopharyngeal Cancer is officially launched
  on BOC Life membership platform“Live Young”. From December 2021 onwards, BOC Life
  insurance clients can earn points through their health metrics for different rewards,
  including the Take2 Prophecy™ Test for NPC.
href: ''
slug: ''
languages:
- en

---
![](../images/untitled-design-31.png)

The Take2 Prophecy™ Test for Nasopharyngeal Cancer is officially launched on BOC Life membership platform“Live Young”. From December 2021 onwards, BOC Life insurance clients can earn points through their health metrics for different rewards, including the Take2 Prophecy™ Test for NPC.

Live Young is a wellness platform APP launched by BOC Life in 2021. It engages users to embrace a healthy lifestyle alongside their families and friends and is supported by thirty-five selected merchants. This initiative matches seamlessly with Take2 Health’s belief to improve everyone’s health by harnessing the power of science and technology. Take2 Health is currently the first and sole provider for early cancer detection test on “Live Young”, with a long-term commitment to creating a comprehensive health ecosystem jointly.